Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glutaphos is an over-the-counter neurotonic supplement developed and marketed by Pascual Laboratories in the Philippines. It is formulated as a "brain vitamin" to enhance mental faculties such as memory, concentration, alertness, and productivity, particularly during periods of mental and physical fatigue. The product contains a combination of four active ingredients: glutamic acid (325 mg), dicalcium phosphate (200 mg), thiamine hydrochloride (Vitamin B1, 5 mg), and cyanocobalamin (Vitamin B12, 10 mcg). Glutamic acid serves as a precursor to the excitatory neurotransmitter glutamate, while the B-vitamins support nerve cell function, energy metabolism, and myelin maintenance. It is widely available in tablet form and is positioned for students and professionals seeking to optimize cognitive performance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glutaphos.